Leading International Distributors Expand Customer Access to Caliper Microfluidics and Drug Discovery Technologies
HOPKINTON, Mass., Feb. 10 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP ) today announced sales distribution partnerships in China, Hong Kong and India. Gene Company Limited and Micro Devices Metrohm Limited (MDML) will be distributing Caliper's discovery product line, which includes its Caliper Sciclone liquid handling products, the LabChip(R) 3000 Drug Discovery System, LabChip 90 Automated Electrophoresis System, and NovaScreen Bioscience's assay development, screening, and profiling services.
Gene Company Limited is a leading distributor of biotechnology products in China and Hong Kong, supplying genomics, proteomics, biochip, and stem cell research centers. MDML is a major supplier of scientific and analytical instruments, serving life science customers throughout India.
"China and India are experiencing a growing need for sophisticated drug development tools and services. Our strategy is to maximize Caliper's share of the drug discovery market in those geographies by teaming up with premier companies in each region," said Kevin Hrusovsky, president and chief executive officer of Caliper Life Sciences. "Gene Company and MDML have proven track records and share our vision of providing innovative, high quality solutions for life sciences."
"We are already planning a variety of pre-selling support activities, such as participation in IBC Asia's BioPharma Opportunities China conference this June in Shanghai," said Jean-Louis Rufener, Caliper's vice president of international operations. "We are also keenly aware of the need to ensure smooth post-sale installation and field service operations, and are 100% committed to achieving resounding success in these regions."
Caliper has established an extensive international distributor network, covering 35 countries in Latin America, Eastern Europe, the Middle East and Asia Pacific. The company also maintains a direct sales force for North America, Western Europe, and Japan. Approximately 35 percent of Caliper's revenues are derived from international sales.
About Caliper Life Sciences
Caliper Life Sciences uses its leading microfluidics patent estate, innovative automation technologies, and broad assay expertise to accelerate drug discovery, enable diagnosis of disease and facilitate scientific research. With the acquisition of NovaScreen Biosciences in October 2005, Caliper provides a unique central resource for drug discovery systems and services.
Caliper headquarters are located in Hopkinton, MA, with R&D, operations and manufacturing facilities for LabChip devices in Mountain View, CA, NovaScreen service operations in Hanover, MD and direct sales, service and applications support throughout the world. The company's customers and Caliper Driven partners include many of the largest pharmaceutical, biotechnology, and life sciences companies. http://www.caliperLS.com
